Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
NCT04473625 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 291
Last updated 2022-06-06
Summary
The primary objective of this sub-study is to obtain de-identified, clinically characterized, stool specimens from subjects with untreated solid tumors for research use in the development and validation of a stool-based test for colorectal cancer.
Conditions
Interventions
- OTHER
-
Stool Sample Collection
Subjects participating in the study will provide a stool sample within 30 days of enrollment.
Sponsors & Collaborators
-
Exact Sciences Corporation
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-21
- Primary Completion
- 2022-03-31
- Completion
- 2022-05-25
Countries
- United States
Study Locations
More Related Trials
-
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
NCT01260168 ·Status: COMPLETED
-
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
NCT01600209 ·Status: COMPLETED
-
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
NCT04144751 ·Status: COMPLETED
-
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
NCT04722055 ·Status: COMPLETED
-
Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection
NCT03146520 ·Status: COMPLETED
-
Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
NCT05232721 ·Status: UNKNOWN
-
Colon Cancer Study of Fecal Samples in Shanghai, China
NCT01778595 ·Status: COMPLETED
-
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
NCT05115786 ·Status: UNKNOWN
-
Treatment Response Prediction System of mCRC Patients Based on CTC
NCT04917276 ·Status: NOT_YET_RECRUITING
-
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
NCT03741166 ·Status: COMPLETED
-
A Multi-center Trial to Establish a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03676075 ·Status: UNKNOWN
-
Evaluation of Different Colorectal Cancer Screening Strategies
NCT05440565 ·Status: UNKNOWN ·Phase: NA
-
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT00899626 ·Status: RECRUITING
-
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00843375 ·Status: RECRUITING
-
Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
NCT05127096 ·Status: UNKNOWN
-
Tumoral Circulating Cells and Colorectal Cancer Progression
NCT03256084 ·Status: UNKNOWN ·Phase: NA
-
Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study
NCT04739722 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Different Fecal Occult Blood Test for Colorectal Cancer Screening
NCT04454099 ·Status: COMPLETED
-
A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer
NCT05255588 ·Status: COMPLETED
-
Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors
NCT04980443 ·Status: COMPLETED ·Phase: NA
-
Relapse Markers for Colorectal Cancer
NCT04920955 ·Status: COMPLETED
-
Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma
NCT01511653 ·Status: COMPLETED
-
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
NCT06059963 ·Status: RECRUITING
-
Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low-and Middle-Income Countries
NCT05679960 ·Status: SUSPENDED ·Phase: NA
-
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
NCT06100016 ·Status: RECRUITING